Abstract: Human monocytes adhere to activated platelets, resulting in the formation of plateletmonocyte complexes (PMC). Complex formation depends on the interaction between platelet-displayed P-selectin and the specific ligand for Pselectin on leukocytes, P-selectin glycoprotein ligand-1 (PSGL-1). We have recently shown that monocytes within PMC have increased adhesive capacity to the activated endothelium. To better understand the effect of platelet binding on the capacity of monocytes to adhere to activated endothelium, the P-selectin-PSGL-1 interaction-induced changes in integrin functionality were studied. The binding of platelets to monocytes via Pselectin-PSGL-1 interactions was shown to increase expression and activity of ␣ 4 ␤ 1 and ␣ M ␤ 2 integrin, with a concomitant decrease in L-selectin expression. Furthermore, the binding of platelets to monocytes resulted in increased monocyte adhesion to intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and fibronectin. Platelet binding was also responsible for an increase in monocyte transendothelial migration. Similar effects were observed after engagement of PSGL-1 with specific antibodies or with P-selectin immunoglobulin protein. Our data suggest that platelets, by binding via P-selectin to PSGL-1 on monocytes, induce up-regulation and activation of ␤ 1 and ␤ 2 integrins and increased adhesion of monocytes to activated endothelium. Hence, monocytes within PMC are in a higher state of activation and may have, therefore, an increased atherogenic capacity. J. Leukoc. Biol. 79: 499 -507; 2006.
INTRODUCTION
Although monocyte adhesion to the damaged endothelium is essential for atherogenesis, platelet recruitment to atherosclerotic lesions is responsible for acute thrombo-embolic events causing myocardial infarction [1] [2] [3] [4] [5] . The interactions between platelets and monocytes might therefore modulate thrombosis and atherogenesis. In this respect, platelet-leukocyte complexes in the circulation are known markers of platelet activation associated with vascular damage caused by atherosclerotic lesions [6, 7] .
Activated platelets express P-selectin, a member of the selectin family, which upon activation, is translocated from the ␣-granules to the platelet surface [8, 9] . The main ligand for P-selectin is P-selectin glycoprotein ligand-1 (PSGL-1), a disulfide-linked homodimer with a molecular weight of ϳ220 kDa on platelets and most leukocytes [10 -12] . P-selectin and PSGL-1 are considered to mediate platelet-monocyte interactions, which not only mediate the binding of leukocytes to activated platelets or thrombi localized at the injured vessel wall but also the formation of platelet-leukocyte complexes [mainly platelet-monocyte complexes (PMC)] in the circulation [2, 13, 14] .
Monocytes, as other leukocytes, are recruited to cytokineactivated endothelium in a multistep process. Initially, monocytes in the bloodstream have to be slowed down by a capturing mechanism and roll over the endothelial layer. Activation of the monocytes during the rolling phase will result in firm adhesion and transmigration [15] [16] [17] . Although the latter process is mediated by interactions between the leukocyte integrins and their endothelial ligands, capture and rolling are mainly mediated by selectins and their respective receptors [17] [18] [19] . By comparing monocytes and PMC regarding their capacity to adhere to the endothelium, we have previously shown that PMC are more adhesive. This increased adhesion is to a large extent dependent on enhanced monocyte-PMC interactions leading to the formation of flow-oriented monocyte and PMC clusters. P-selectin-PSGL-1 interactions are involved in the formation of these secondary tethers [14] . P-selectin has been shown to increase ␤ 2 integrin functionality on neutrophils [20 -22] and to enhance the nuclear transcription of nuclear factor-B, which is required for the production of cytokines such as monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor ␣ (TNF-␣) [23] . The idea of PSGL-1 ligation-mediated signaling has been emphasized by the observation that cross-linking of PSGL-1 on neutrophils induced protein-tyrosine phosphorylation, activated mitogen-activated protein kinases (MAPK), and stimulated interleukin (IL)-8 secretion. Moreover, PSGL-1 engagement on mouse neutrophils induces lymphocyte function-associated antigen-1 (LFA-1)-and membrane-activated complex-1 (Mac-1)-dependent adhesion to intercellular adhesion molecule-1 (ICAM-1) [24] . Furthermore, P-selectin binding to its counterreceptor PSGL-1 promotes ␣ 4 ␤ 1 -dependent adhesion of monocytes to vascular cell adhesion molecule-1 (VCAM-1) [25] .
Altogether, these observations suggest a radical change, quantitatively and qualitatively, in the leukocyte repertoire of surface-expressed adhesion molecules upon platelet binding. In the present study, we focused on the P-selectin-PSGL-1 interaction to better characterize the effect of platelet binding on the adhesive capacity of monocytes to activated endothelium.
MATERIALS AND METHODS

Reagents
Human serum albumin (HSA) was purchased from Sanquin Immunoreagents (Amsterdam, The Netherlands). Bovine serum albumin (BSA) and phorbol 12-myristate 13-acetate (PMA) were from Sigma-Aldrich (St. Louis, MO). Recombinant TNF-␣ was from Boehringer Mannheim (Germany), and recombinant MCP-1 was from Strathman Biotech (Hannover, Germany). Alexa Fluor-488 phalloidin and Hoechst 33258 were from Molecular Probes (Eugene, OR). Washing buffer contained phosphate-buffered saline (PBS) supplemented with 0.5% HSA and 13 mM trisodium citrate. Incubation buffer contained 20 mM HEPES, 132 mM NaCl, 6 mM KCl, 1 mM MgSO 4 , and 1.2 mM KH 2 PO 4 supplemented with 5 mM glucose, 1.0 mM CaCl 2 , and 0.5% (w/v) HSA. Iscove's modified Dulbecco's medium (IMDM) was from BioWhittaker (Verviers, Belgium), and other tissue-culture supplies (media, antibiotics, and trypsin) were from Gibco, Life Technologies Inc. (Paisley, UK).
Cell culture
Human umbilical vein endothelial cells (HUVEC) were isolated from human umbilical cord veins as described previously [26, 27] . Cells were cultured in RPMI 1640 containing 20% (v/v) human serum and 200 g/ml penicillin and streptomycin (Gibco, Life Technologies Inc.) and were grown to confluence in 5-7 days. EC from the third passage were used in the experiments. TNF-␣ (100 U/ml) was added to the medium 6 h prior to the experiments. U937 cells (a monocytic cell line derived from human histiocytic lymphoma) were purchased from the American Type Culture Collection (ATCC; Manassas, VA). The cells were cultured in RPMI 1640 (Gibco, Life Technologies Inc.) containing 10% (v/v) heat-inactivated fetal calf serum (Gibco, Life Technologies Inc.), 2 mM L-glutamine, 50 IU/ml penicillin, and 50 g/ml streptomycin (complete medium).
Proteins and monoclonal antibodies (mAb)
Human P-selectin-Fc chimera, ICAM-1-immunoglobulin G (IgG), and VCAM-1-IgG were purchased from R&D Systems (Minneapolis, MN). Human plasma fibronectin was from Sigma-Aldrich. The antibodies used in the present study are described in Table 1 . The hybridomas for mAb WASP12.2, DREG56, IB4, 44a, and W6/32 were from the ATCC. The CD11b conformation-dependent antibody CBRM1/5 and the antibodies against PSGL-1, PL-1 and PL-2, were kindly provided by Dr. Kevin L. Moore (University of Oklahoma, Norman). KPL-1 was from Santa Cruz Biotechnology (CA). Antibodies 1G11 and 84H10 were from Immunotech (Marseille, France). The ␤ 1 integrin conformation-dependent mAb HUTS21 was a kind gift of Dr. Francisco Sanchez-Madrid (Hospital de La Princesa, Madrid, Spain). The FITC-labeled 44H6 mAb was from Chemicon International (Temecula, CA), and the FITC-labeled DREG56 antibody was from Becton Dickinson (San Jose, CA). The Alexa-488-labeled goat antimouse (GAM) Ig antibody was from Molecular Probes. All the other antibodies were purchased from Sanquin Immunoreagents. Human and mouse IgG were purchased from Sigma-Aldrich. 
Monocyte isolation
Whole blood, anticoagulated with 0.4% trisodium citrate (pH 7.4), was obtained from healthy volunteers from the Sanquin Blood Bank (Amsterdam, The Netherlands). Monocytes were negatively selected from human peripheral blood by means of a magnetic cell sorter monocyte isolation kit according to the manufacturer's instructions (Miltenyi Biotech GMBH, Bergisch Gladbach, Germany). This procedure resulted in monocyte fractions containing more than 90% monocytes (CD14 ϩ cells in FACScan), the viability exceeding 95% (as determined by Trypan blue exclusion). The percentage of PMC present in these monocyte suspensions was determined by counting the CD14 ϩ /CD42 ϩ events. We observed that 10 -20% of the monocytes had platelets bound to their surface. To obtain PMC-poor monocyte suspensions, the monocytes were incubated with a mouse IgG mAb against GPIIIa (platelet ␤ 3 integrin, clone AP3, hybridoma from the ATCC) for 20 min at 4°C. After one washing step, the cells were incubated with goat anti-mouse-IgG microbeads (Dynabeads, Dynal A.S., Oslo, Norway) at a ratio of two beads per platelet for 20 min at 4°C. After magnetic extraction of the beads, the number of PMC was less than 5% of the total number of monocytes. After isolation, the cells were resuspended in incubation buffer. For blocking experiments, monocyte suspensions with or without PMC were incubated with mAb for 10 min at 37°C prior to the perfusion experiments. In some instances, washed platelets were added to the monocyte suspension just before perfusion. Addition of one or three platelets per monocyte resulted in platelet binding to 10 -20% or to 20 -40% of the monocytes, respectively.
Platelet isolation
Whole blood was centrifuged at 150 g for 10 min to obtain platelet-rich plasma, which was diluted 1:1 in Krebs-Ringer solution [4 mM KCl, 107 mM NaCl, 20 mM NaHCO 3 , 2 mM Na 2 SO 4 , 19 mM tri-sodium citrate, 0.5% (w/v) glucose in H 2 O, pH 5.0]. The mixture was centrifuged at 500 g for 10 min, and the supernatant was removed. The platelets in the pellet were resuspended in 2 ml Krebs-Ringer solution and centrifuged at 500 g for 10 min. This process was repeated two times, and the final suspension was made up in Krebs-Ringer (pH 6.1) solution to a concentration of 300,000 platelets/l.
Adhesion assay
Adhesion assays were performed as described previously [28 -32] with some modifications. Briefly, 96-well microtiter plates (No. 3596, Corning Costar, Cambridge, MA) were coated by incubation with fibronectin (10 g/ml), VCAM-1, or ICAM-1/Fc chimera (1 g/ml) for 1 h at 37°C or 4% HSA as control for 1 h at 37°C. After incubation, the wells were washed with PBS and then blocked with 4% HSA at 37°C for 30 min. Control wells were filled with 4% HSA in PBS. Monocytes were labeled with calcein alveolar macrophage (Molecular Probes) at a final concentration of 5 g/1 ϫ 10 7 cells. In some instances, monocytes were incubated with platelets or P-selectin after calcein labeling. For PMA stimulation, cells were added to wells containing 10 ng/ml PMA. For blocking experiments, cells were added to wells containing the function-blocking mAb. Plates were then incubated at 37°C, and the monocytes were allowed to settle for 30 min. After incubation, nonadherent cells were removed by washing twice with PBS, and adherent cells were lysed in 0.5% Triton X-100 for 10 min at room temperature. Adhesion was quantified with a microplate fluorescence plate reader (GENios Plus, Tecan Group Ltd., Männedorf, Switzerland). Fluorescence was measured at excitation wavelength 485 nm and emission wavelength 525 nm. The adhesion ratio (%) was calculated as follows: (fluorescence from experimental sample-fluorescence from negative control sample)/total fluorescence added to well ϫ 100%.
Monocyte perfusion and evaluation of cell adhesion
Monocytes in suspension (2ϫ10 6 cells/ml in incubation buffer at 37°C) were aspirated from a reservoir through plastic tubing, a valve, and the flow chamber [27, 33] with a Harvard syringe pump (Harvard Apparatus, South Natic, MA). The flow rate through the chamber was controlled precisely (according to the manufacturer's instructions), and the shear stress was kept at 0.8 dyn/cm 2 . The wall shear stress was calculated according to the Navier Stokes equation: t ϭ (6Q.)/(w.h 2 ). In this equation, Q is the flow rate, is the suspending-medium viscosity, w is the slit width, and h is the slit height of the flow chamber [33] .
The shear stress is proportional to the rate of flow of the cells and can be calculated as dyn/cm 2 . During perfusions, the flow chamber was mounted on a microscope stage (Axiovert 25, Zeiss, Germany), equipped with a black and white charged-coupled device video camera (Sanyo, Osaka, Japan) and coupled to a VHS video recorder. Video images were evaluated for the number of adherent monocytes and the rolling velocity per cell with dedicated routines made in the image analysis software Optimas 6.1 (Media Cybernetics Systems, Silver Spring, MD). The monocytes, which were in contact with the surface, appeared as bright, white-centered cells after proper adjustment of the microscope during recording. The number of surface-adherent monocytes was measured after 5 min of perfusion at a minimum of 25 randomized, high-power fields. The rolling velocity of cells was measured as described previously [34] . In short, a sequence of 50 frames representing an adjustable time interval (␦t, with a minimal interval of 80 ms) was captured digitally. The position of every cell was detected in each frame, and for all subsequent frames, the distance traveled by each cell and the number of images in which a cell appears in focus were measured. The cut-off value to distinguish between rolling and static adherent cells was set at 1 m/s. With this method, static adherent, rolling, and free-flowing cells (which were not in focus) could be clearly distinguished.
Flow cytometry and confocal microscopy to determine cell adhesion molecules expression upon PSGL-1 engagement on monocytes Calibration of the flow cytometer was performed according to a standard procedure, which has been set and approved by the Dutch Foundation for Quality Assessment in Clinical Laboratories (SKML; Nijmegen, The Netherlands). Expression of adhesion molecules on the monocyte surface was investigated by flow cytometry (FACSVantage, Becton Dickinson) with cells that were incubated, or not, with platelets (see Monocyte isolation in Materials and Methods) or with a P-selectin Ig. By distinguishing between monocytes with no platelets bound to their surface (CD42b -) and platelet-bound monocytes (CD42b ϩ ), two different populations of monocytes were characterized, regarding the expression of different adhesion molecules. The expression of CD62L, CD18, CD11a, CD11b, CD29, and CD49d was determined by incubating monocytes with specific, directly labeled antibodies for 1 h at 4°C (according to the manufacturer's instructions). Samples were also incubated with isotypematched control antibodies (IgG 1 and IgG 2 a, considering the antibody of interest, see Table 1 ). Integrin activation was investigated by incubating monocytes with the purified antibodies CBRM1/5 (activation-dependent epitope on ␣ M subunit) or HUTS21 (activation-dependent epitope on ␤ 1 integrins) or the respective isotype control antibodies (unlabeled IgG1 and IgG2a, see Table 1 ) for 1 h at 4°C. After washing one time with washing buffer, cells were further incubated with Alexa-488-labeled goat anti-mouse Ig antibody.
To further investigate the integrin expression and activation state induced by PSGL-1 engagement by P-selectin, the distribution of ␣ M ␤ 2 (CD11b) and ␣ 4 ␤ 1 (CD49d) was characterized by confocal microscopy. Monocytes, untreated or treated with P-selectin Ig or PMA (positive control), were fixed with 3.7% formaldehyde in PBS containing 1 mM Ca 2ϩ and 1 mM Mg 2ϩ for 10 min at room temperature. After blocking with PBS containing 0.5% (w/v) BSA, 1 mM Ca 2ϩ , and 1 mM Mg 2ϩ , the expression of CD11b and CD49d was detected with the FITC-labeled antibodies. Images were recorded with a Zeiss LSM 510 confocal laser-scanning microscope.
Transmigration assay
Monocyte transmigration was studied under flow and static conditions. Monocyte suspensions (containing Ͻ5%, 10 -20%, or 20 -40% PMC) were perfused over 6 h-TNF-␣-activated EC. After 5 min of perfusion, nonadherent cells were washed away, and incubation medium was perfused further for 10 min. The adherent cells that migrated through the EC layer were manually counted every 2 min.
Transmigration assays under static conditions were performed in 6.5 mm, 5 m pore Transwell plates (Corning Costar), coated with fibronectin. Freshly isolated monocytes or PMC (1ϫ10 5 ) were added to the upper compartment in 0.1 ml assay medium [IMDM medium with 0.25% (w/v) BSA], and 0.6 ml assay medium with 10 ng/ml recombinant human MCP-1 were added to the lower compartment. The Transwell plates were then incubated at 37°C, 5% CO 2 , for different time periods (30, 60, 90 , and 120 min). Cells that migrated to the lower compartment were collected in a tube to which a fixed number of control U937 cells, labeled with 
Statistical analysis
Data are represented as the mean Ϯ SD of three to five independent experiments, and comparisons were analyzed using the Mann-Whitney U test. All effects were assessed at the 0.05 level of significance.
RESULTS
PSGL-1 ligation by P-selectin increases monocyte adhesion to immobilized fibronectin, VCAM-1, and ICAM-1
To test the effect of P-selectin in monocyte adhesiveness, we analyzed changes in monocyte adhesion to fibronectin. Freshly isolated monocytes were treated with various concentrations of P-selectin Ig and added to fibronectin-coated wells of tissueculture plates. After incubation at 37°C for 30 min, unbound cells were washed with PBS, and bound monocytes were quantified. P-selectin Ig enhanced monocyte adhesion to fibronectin in a concentration-dependent manner. A maximal effect was obtained at 10 g/ml (data not shown).
We further characterized the adhesive capacity of monocytes after PSGL-1 engagement by platelets or P-selectin Ig to various immobilized proteins (fibronectin, VCAM-1, and ICAM-1). Monocytes were incubated with different concentrations of platelets (allowing the formation of PMC, see Monocyte isolation in Materials and Methods) or with P-selectin Ig (10 g/ml). As shown in Figure 1A , platelets enhance monocyte adhesion to the different protein surfaces in a concentration-dependent manner. The strongest effect was obtained when three platelets per monocyte were added (20 -40% PMC). Similarly, the binding of P-selectin also enhanced monocyte adhesion to the different surfaces (Fig. 1B) .
To verify the specificity of this effect, i.e., the role of platelets and integrins, the physical interaction of platelets with monocytes was inhibited by antibodies to cell surface receptors. A blocking antibody against P-selectin blocked the increment in monocyte adhesion to all immobilized proteins (Fig. 2) . When monocytes 
Fig. 2.
Antibodies against integrins or P-selectin block the platelet-dependent effect on monocyte adhesion. Monocytes were left untreated (control, open bars) or were treated with P-selectin Ig (-). For antibody inhibition experiments, P-selectin Ig was treated with WASP12.2 (a P-selectin-blocking antibody) prior to incubation with monocytes. Incubation with W6/32 (anti-HLA-A, -B, and -C, control antibody), HP2/1 (a CD49d-blocking antibody), and IB4 (a CD18-blocking antibody) or 44A (a CD11b-blocking antibody) was performed after binding of P-selectin Ig to the monocytes and before adding them to the wells on the tissue-culture plate. As a control, monocytes were also incubated with mouse IgG (mIgG 1 ), prior to addition to the coated wells. After incubation at 37°C, the plates were washed, and the bound cells were lysed with 0.5% w/v Triton X-100 for 10 min at room temperature. Plates were then read on a microplate fluorescence plate reader at excitation wavelength 485 nm and emission wavelength 525 nm. All results are expressed as the mean Ϯ SD values of adherent cells/mm 2 of three independent experiments (**, PϽ0.01; *, PϽ0.05).
were incubated with HP2/1 (a mAb to integrin ␣ 4 ␤ 1 , which blocks leukocyte adhesion), the increment in monocyte adhesion to fibronectin or VCAM-1 was abrogated completely. Similarly, when monocytes were preincubated with IB4 (a mAb to the integrin ␤ 2 subunit, which blocks leukocyte adhesion) or 44a (a blocking mAb to integrin ␣ M ), the monocyte adhesion to ICAM-1 was low. A mouse IgG 1 antibody had no detectable effect. These data indicate that P-selectin specifically increases monocyte adhesion and suggests that the increased adhesion is mediated by ␤ 1 and ␤ 2 integrins.
Adhesion of monocytes to extracellular matrix and endothelial substrates under flow conditions
We next examined the effects of PSGL-1 engagement on monocyte adhesiveness to fibronectin, VCAM-1, and ICAM-1 under flow conditions. Similar to the results obtained under static conditions, also under flow conditions, we observed a significant increase in monocyte adhesion to the different protein surfaces (Fig. 3, upper graphic) .
To determine whether integrin activation, modulated by PSGL-1-P-selectin binding, changes the monocyte capacity to adhere to a model of inflamed endothelium, we perfused freshly isolated monocytes, incubated or not with platelets or with P-selectin Ig, over TNF-␣-activated HUVEC (Fig. 3, lower  graphic) . We have previously shown [14] that monocytes do not adhere to unstimulated endothelium under flow conditions. We have performed similar control experiments, which confirmed this (data not shown). Therefore, monocyte adhesion to the endothelium was used as control for proper stimulation of the EC by TNF-␣. When the PMC content in the monocyte suspension was less than 5%, blocking antibodies to VLA-4 or Mac-1 (on monocytes) and VCAM-1 or ICAM-1 (on HUVEC) reduced monocyte adhesion by 30%. As expected and as shown before [14] , a P-selectin-blocking antibody (WASP12.2) did not have an effect on monocyte adhesion under these conditions. With a PMC content of 20 -40%, the same integrin-blocking antibodies also inhibited monocyte adhesion to HUVEC. However, a stronger inhibitory effect (50%) was obtained by blocking P-selectin on platelets.
Flow cytometric analysis of ␤ 1 and ␤ 2 integrin expression on P-selectin-or platelet-bound monocytes
We analyzed the expression of ␣ 4 ␤ 1 and ␣ M ␤ 2 integrins on monocytes and determined whether P-selectin binding enhanced the level of integrins expressed on the monocyte surface. PSGL-1 ligation on monocytes was induced by incubation of monocytes with P-selectin Ig or with different amounts of platelets (see Materials and Methods). In Figure 4 , a histogram representative of the expression pattern of adhesion molecules on the surface of cells from the two distinct monocyte subpopulations (naked monocytes and monocytes with platelets on their surface, PMC) is shown. Clear differences regarding the expression of CD11a and CD62L on monocytes from the two subpopulations can be observed. After analyzing the expression of several other adhesion molecules, the differences between the two subpopulations were quantified and are indicated in Table 2 . Platelet-or P-selectin-bound monocytes showed increased expression of ␣ 4 ␤ 1 and ␣ M ␤ 2 integrins (CD49d and CD11b, respectively, Table 2, *PϽ0.05), and a decrease in L-selectin expression was observed, suggesting monocyte activation upon P-selectin binding. When P-selectin or platelet binding to monocytes was blocked by incubation of the cells with the anti-P-selectin mAb WASP12.2, no increase in integrin expression was observed, as shown previously [14] . Although the increase in integrin expression on platelet-bound monocytes was stronger, an increase in ␤ 2 integrin expression was also observed on the naked monocytes within the suspensions to which platelets were added, suggesting some degree of cell activation.
Integrin activation was assessed by the use of specific antibodies such as CBRM1/5 and HUTS21. CBRM1/5 antibody reacts with an activation-dependent epitope on the ␣ M subunit (Mac-1), and HUTS21 antibody reacts with an activationdependent epitope on ␤ 1 integrins. Incubation of monocytes with platelets or with P-selectin Ig resulted in a three-to fivefold increase in ␤ 1 and ␤ 2 integrin activation (Fig. 5) . Although the naked monocytes in PMC-rich suspensions did show a partial increase in integrin expression, these integrins were not activated.
Besides the effect of P-selectin binding to PSGL-1, also, the influence of specific PSGL-1 antibodies (KPL-1, PL-1, and PL-2) on integrin up-regulation on monocytes was investigated. Addition of PL-2 (a nonblocking PSGL-1 antibody), KPL-1, or PL-1 (two blocking mAb to PSGL-1) to monocytes (no platelets present) also resulted in increased integrin expression and activation (Fig. 6) . These results indicate that mAb interaction with PSGL-1 on monocytes is sufficient to induce functional up-regulation of ␤ 1 and ␤ 2 integrins.
Confocal microscopy analysis of integrin expression on P-selectin-bound monocytes
To further characterize the integrin expression and activation induced by P-selectin binding to the monocytes, the distribution of ␣ 4 ␤ 1 and ␣ M ␤ 2 integrins on the monocyte surface was investigated by confocal microscopy (Fig. 7) . Nontreated cells (control) stained for CD11b or CD49d showed only a weak and punctuated staining for both antibodies. As a positive control, PMA stimulation strongly induced a bright staining pattern.
Stimulation by P-selectin Ig chimera resulted in an intermediate staining pattern, and the patches were larger and more abundant than in the control conditions. These data indicate induction of variable degrees of avidity of ␣ M ␤ 2 and ␣ 4 ␤ 1 integrins by P-selectin and PMA. As the effect of platelet binding to monocytes on integrin up-regulation was so clear, the results were not quantitated. Fig. 4 . Monocytes show a different pattern in the expression of adhesion molecules depending on the binding or absence of platelets on their surface. Monocytes were incubated with platelets to allow the formation of PMC (three platelets per monocyte, resulting in the formation of 20 -40% PMC in the monocyte suspension; see Materials and Methods). Incubation of this cell suspension with a CD42b/PE antibody was used to distinguish two populations of monocytes: monocytes (no platelets bound to their surface and thus, CD42b -) and PMC (monocytes with platelets bound to their surface and thus, CD42b ϩ ). To investigate whether monocytes belonging to the two subpopulations show differences in an integrin-expression pattern, monocytes belonging to each subpopulation were analyzed regarding the expression of LFA-1 (CD11a) and L-selectin (CD62L) as described in Materials and Methods. The presented data are representative images of three independent experiments. 
Effect of platelet binding on monocyte transmigration
We further investigated a possible correlation between the observed increase in monocyte adhesion to HUVEC upon PSGL-1 ligation and an increase in monocyte transmigration. An increase in monocyte transmigration was observed when 20 -40% PMC were present. Under static conditions, the percentage of migration toward MCP-1 was 25% higher when PMC were present (Fig. 8) . PMC presence also influenced monocyte transmigration under flow conditions, as 50% of the cells migrated within the first 6 min of perfusion, and in the absence of PMC, this process took 10 min (data not shown).
DISCUSSION
Interactions of PSGL-1 with P-selectin mediate the initial tethering of leukocytes to activated platelets or EC at sites of infection or tissue injury [13, 35] . We recently showed that PMC support monocyte adhesion by enhancing secondary tethering [14] . In the present study, we extend our previous work by investigating the consequences of platelet binding on the monocyte phenotype regarding expression of ␤ 1 and ␤ 2 integrins and the adhesive capacity to an inflamed endothelium model. We demonstrated that platelet binding to monocytes induces a high monocyte-activation state, characterized by down-regulation of L-selectin and rapid activation of ␣ 4 ␤ 1 and ␣ M ␤ 2 integrins. Similar effects on monocyte activation were observed after ligation of PSGL-1 by P-selectin Ig chimera or by specific antibodies to PSGL-1. This P-selectin-triggered integrin activation was blocked completely by a blocking antibody to P-selectin, indicating that physical binding of Pselectin to PSGL-1 on monocytes is essential for this process. In fact and although the naked monocytes within the monocyte suspensions to which platelets have been added show a slight increase in integrin expression as a result of possible reversible platelet binding or platelet-released effectors, their integrin functionality remains unchanged. P-selectin-triggered signaling and its stimulatory effects on human leukocytes have been described in several previous reports. P-selectin binding to PSGL-1 has been shown to promote ␤ 2 integrin-dependent homotypic neutrophil aggregation and neutrophil-platelet conjugation [22, 36] . Hidari et al. [24] demonstrated that ligation of PSGL-1 on human neutrophils with mAb or with P-selectin increased protein tyrosine phosphorylation, activated the extracellular signal-regulated kinase and MAPK, and induced secretion of IL-8. Monocytes, upon binding of activated platelets, were shown to secrete MCP-1 and IL-8 [37] and to express tissue factor [38 -40] .
Various mechanisms for a role of P-selectin in influencing the activity of ␤ 1 and ␤ 2 integrins have been suggested. However, most studies have shown that P-selectin cannot stimulate integrin activation directly on human leukocytes [20, 37, 40] . Instead, P-selectin was described as an anchoring molecule, allowing monocytes to bind to activated endothelium, thus facilitating the binding of EC surface-bound platelet-activating factor (PAF) to its receptor on the leukocyte surface. Subsequently, immobilized chemoattractant PAF induced integrin activation [20] . Our data indicate that the increase in integrin expression and activation occurs upon PSGL-1 ligation by platelets, P-selectin, or PSGL-1-specific antibodies. We observed an increase in monocyte adhesion to immobilized fibronectin, VCAM-1, and ICAM-1, indicative of integrin conformational changes. Furthermore, upon platelet binding to monocytes, there was an increase in ␣ M ␤ 2 -and ␣ 4 ␤ 1 -dependent adhesion of monocytes to activated EC under flow conditions. This is in agreement with previous studies showing induction of ␣ M ␤ 2 integrin upon platelet binding to human neutrophils [20, 21, 41] and an increased affinity of monocytes to VCAM-1 by P-selectin binding under flow conditions [4, 25, 42] .
The presence of additional platelet-released, synergistic factors, such as the cytokines PAF and regulated on activation, normal T expressed and secreted [4] , seems to be required to induce optimal leukocyte activation. This might explain the observed monocyte adhesion upon P-selectin-Ig binding or PSGL-1 antibodies, which was in some instances lower than the one obtained by adding freshly isolated platelets to monocytes. A recent study [20] about neutrophils suggested an intermediate state of integrin activation induced by engagement of PSGL-1 by P-selectin Ig or antibodies to PSGL-1. This intermediate integrin activation state is compatible with a moderate increase in monocyte adhesion to immobilized proteins or activated EC. Furthermore, depending on the leukocyte type, PSGL-1 structure and subsequent affinity for its main ligand, P-selectin, seem to differ. When compared with neutrophils, PSGL-1 on eosinophils has been shown to bind tenfold stronger to P-selectin [43] . Recently, platelets were shown to preferentially bind monocytes over neutrophils under flow [44] , suggesting differences in structure/affinity of PSGL-1 on the two different cell types. These differences might result in the induction of different PSGL-1-mediated integrin-signaling pathways and explain the effect of platelet binding on integrin expression and activation observed by us, in contrast to others [20] .
In conclusion, our data show an increase in expression and adhesive capacity of ␣ 4 and ␣ M integrins upon PSGL-1 ligation by P-selectin on human monocytes. PSGL-1 ligation by platelet binding results in increased integrin activation and subsequently, increased cell adhesion to fibronectin, VCAM-1, ICAM-1, and activated EC. Although an increase in monocyte transmigration was also observed, the exact role of platelets in this phenomenon needs further investigation.
The concerted action of a variety of stimuli such as chemoattractants and P-selectin, provided by platelet binding, seems to modulate the activation of monocyte integrins relevant for the monocyte extravasation process and thus, for their atherogenic capacity.
